Telmisartan, an angiotensin II type-1 receptor blocker, improved insulin resistance in a schizophrenic patient treated with olanzapine: a case report.
Yamashita
Hakuei
H
Yoda
Hiroo
H
Maruki
Taeko
T
Toyoshima
Ryoichi
R
D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*; D000077333:Telmisartan
D047228:Angiotensin II Type 1 Receptor Blockers; D014150:Antipsychotic Agents; D001562:Benzimidazoles; D001565:Benzoates; D001569:Benzodiazepines; D000077152:Olanzapine; D000077333:Telmisartan